Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Shepherd

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|May 1, 1991
Sexual behaviour changes in a cohort of male sexual contacts of men with HIV disease: a three-year overviewL M Calzavara, R A Coates, K Johnson, et al.
Annals of Internal Medicine|October 1, 1987
Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of CanadaW K Evans, R Feld, N Murray, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|September 1, 1986
The reliability of sexual histories in AIDS-related research: evaluation of an interview-administered questionnaireR A Coates, C L Soskolne, L Calzavara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patientsP Ruffie, R Feld, S Minkin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Dexamethasone/ifosfamide/cisplatin/etoposide (DICE) as therapy for patients with advanced refractory non-Hodgkin's lymphoma: preliminary report of a phase II studyP E Goss, F A Shepherd, J G Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicinD J Stewart, W K Evans, F A Shepherd, et al.
Cancer|April 1, 1994
Extragonadal germ cell tumors. A 14-year Toronto experienceP E Goss, L Schwertfeger, M E Blackstein, et al.
Lung Cancer (Amsterdam, Netherlands)|December 5, 2006
Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: the JBR.10 trial experienceI Gauthier, K Ding, T Winton, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 13, 2012
Pharmacogenetic analysis of BR.21, a placebo-controlled randomized phase III clinical trial of erlotinib in advanced non-small cell lung cancerGeoffrey Liu, D Cheng, K Ding, et al.
British Journal of Cancer|September 23, 1998
Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small-cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group StudyF A Shepherd, M R Johnston, D Payne, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|May 1, 1991
Sexual behaviour changes in a cohort of male sexual contacts of men with HIV disease: a three-year overviewL M Calzavara, R A Coates, K Johnson, et al.
Annals of Internal Medicine|October 1, 1987
Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of CanadaW K Evans, R Feld, N Murray, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|September 1, 1986
The reliability of sexual histories in AIDS-related research: evaluation of an interview-administered questionnaireR A Coates, C L Soskolne, L Calzavara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patientsP Ruffie, R Feld, S Minkin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Dexamethasone/ifosfamide/cisplatin/etoposide (DICE) as therapy for patients with advanced refractory non-Hodgkin's lymphoma: preliminary report of a phase II studyP E Goss, F A Shepherd, J G Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicinD J Stewart, W K Evans, F A Shepherd, et al.
Cancer|April 1, 1994
Extragonadal germ cell tumors. A 14-year Toronto experienceP E Goss, L Schwertfeger, M E Blackstein, et al.
Lung Cancer (Amsterdam, Netherlands)|December 5, 2006
Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: the JBR.10 trial experienceI Gauthier, K Ding, T Winton, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 13, 2012
Pharmacogenetic analysis of BR.21, a placebo-controlled randomized phase III clinical trial of erlotinib in advanced non-small cell lung cancerGeoffrey Liu, D Cheng, K Ding, et al.
British Journal of Cancer|September 23, 1998
Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small-cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group StudyF A Shepherd, M R Johnston, D Payne, et al.
Pageof 18